About Thomas Barnes
Thomas Barnes is CEO & Board Member at Averna Therapeutics.
Experience
This experience comes from Thomas Barnes's profile and from SEC filings. For roles taken from filings, the years are when the filings name Thomas Barnes in the role, so the role may have started earlier or lasted longer.
Averna Therapeutics Inc. Current
CEO & Board Member
Chief Executive Officer (2025 – Present)
2025 – Present · Watertown, MA
Develops gene insertion medicines for people with genetic diseases, cancer and autoimmune conditions.
MB
MPM BioImpact
Executive Partner
2020 – 2024
OT
Orna Therapeutics
Board Member
2020 – 2024
YI
youQ, Inc.
Founder and President
2019 – 2020
II
Intellia Therapeutics, Inc.
Senior Vice President, Innovative Sciences
2014 – 2019
AT
Ascelegen Therapeutics
interim CSO
2014 – 2015
IT
Ipsum Therapeutics
President
2013 – 2015
BC
Barnes Consulting
Principal
2013 – 2014
EI
Eleven Biotherapeutics, Inc
VP Discovery
2009 – 2013
TL
Tengri Therapeutics LLC
Founder
2008 – 2009
OI
Ore Pharmaceuticals, Inc
Sr Vice President, Discovery
2004 – 2008
MP
Millennium Pharmaceuticals
Director, Genomic Pharmacology
1997 – 2004
MU
McGill University
Research Fellow
1993 – 1997
HS
Harvard Medical School
Postdoc
1991 – 1993
BA
Biotechnology Australia
Sr Research Assistant
1983 – 1987
Key Colleagues at Startups
The people Thomas Barnes works with at each company, as listed on that company's latest Form D.
Averna Therapeutics Inc. · Form D/A, Mar 20, 2026
Roy Amariglio
Board Member
Nick Olsen
Board Member
SS
Stephen Squinto
Director
MS
Michal Silverberg
Director
Raju Prasad
Board Member
Tal Zaks
Executive Chairman of the Board
Henry Chen
Board Member
DM
Dylan Morris
Board Member